{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:09:57Z","timestamp":1794380997459,"version":"4.9.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T00:00:00Z","timestamp":1554681600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Suzhou science and technology foundation","award":["SYS2018064"],"award-info":[{"award-number":["SYS2018064"]}]},{"name":"Hospital internal research foundation for PhD","award":["Hospital internal research foundation for PhD"],"award-info":[{"award-number":["Hospital internal research foundation for PhD"]}]},{"DOI":"10.13039\/501100010854","name":"Jiangsu Provincial Commission of Health and Family Planning","doi-asserted-by":"publisher","award":["H201521"],"award-info":[{"award-number":["H201521"]}],"id":[{"id":"10.13039\/501100010854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["Natural Science Foundation of Jiangsu Province"],"award-info":[{"award-number":["Natural Science Foundation of Jiangsu Province"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13046-019-1161-8","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T08:02:39Z","timestamp":1554710559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":186,"title":["Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK\/STAT3\/PD-L1 pathway"],"prefix":"10.1186","volume":"38","author":[{"given":"Mingjing","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanqiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongbing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,8]]},"reference":[{"issue":"7","key":"1161_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ajhp\/59.7.611","volume":"59","author":"RJ Cersosimo","year":"2002","unstructured":"Cersosimo RJ. Lung cancer: a review. Am J Health Syst Pharm. 2002;59(7):611\u201342.","journal-title":"Am J Health Syst Pharm"},{"key":"1161_CR2","doi-asserted-by":"publisher","first-page":"b5569","DOI":"10.1136\/bmj.b5569","volume":"340","author":"A Parsons","year":"2010","unstructured":"Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis. BMJ. 2010;340:b5569.","journal-title":"BMJ"},{"issue":"1","key":"1161_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.lungcan.2010.08.022","volume":"71","author":"A Chang","year":"2011","unstructured":"Chang A. Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC. Lung Cancer. 2011;71(1):3\u201310.","journal-title":"Lung Cancer"},{"key":"1161_CR4","doi-asserted-by":"publisher","first-page":"e1257","DOI":"10.1038\/cddis.2013.428","volume":"5","author":"L Galluzzi","year":"2014","unstructured":"Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, et al. Systems biology of cisplatin resistance: past, present and future. Cell Death Dis. 2014;5:e1257.","journal-title":"Cell Death Dis"},{"issue":"7579","key":"1161_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature15748","volume":"527","author":"KR Fischer","year":"2015","unstructured":"Fischer KR, Durrans A, Lee S, Sheng J, Li F, Wong ST, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. 2015;527(7579):472\u20136.","journal-title":"Nature"},{"key":"1161_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/srep20502","volume":"6","author":"D Huang","year":"2016","unstructured":"Huang D, Duan H, Huang H, Tong X, Han Y, Ru G, et al. Cisplatin resistance in gastric cancer cells is associated with HER2 upregulation-induced epithelial-mesenchymal transition. Sci Rep. 2016;6:20502.","journal-title":"Sci Rep"},{"issue":"7","key":"1161_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/molecules21070965","volume":"21","author":"B Du","year":"2016","unstructured":"Du B, Shim JS. Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in Cancer. Molecules. 2016;21(7):965.","journal-title":"Molecules"},{"issue":"4","key":"1161_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/cdd.2015.133","volume":"23","author":"SK Alam","year":"2016","unstructured":"Alam SK, Yadav VK, Bajaj S, Datta A, Dutta SK, Bhattacharyya M, et al. DNA damage-induced ephrin-B2 reverse signaling promotes chemoresistance and drives EMT in colorectal carcinoma harboring mutant p53. Cell Death Differ. 2016;23(4):707\u201322.","journal-title":"Cell Death Differ"},{"issue":"20","key":"1161_CR9","doi-asserted-by":"publisher","first-page":"29359","DOI":"10.18632\/oncotarget.8833","volume":"7","author":"S Yin","year":"2016","unstructured":"Yin S, Wang P, Yang L, Liu Y, Wang Y, Liu M, et al. Wip1 suppresses ovarian cancer metastasis through the ATM\/AKT\/snail mediated signaling. Oncotarget. 2016;7(20):29359\u201370.","journal-title":"Oncotarget"},{"issue":"7","key":"1161_CR10","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.cellsig.2014.03.028","volume":"26","author":"R Singh","year":"2014","unstructured":"Singh R, Shankar BS, Sainis KB. TGF-beta1-ROS-ATM-CREB signaling axis in macrophage mediated migration of human breast cancer MCF7 cells. Cell Signal. 2014;26(7):1604\u201315.","journal-title":"Cell Signal"},{"key":"1161_CR11","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1038\/ncomms8677","volume":"6","author":"R Russell","year":"2015","unstructured":"Russell R, Perkhofer L, Liebau S, Lin Q, Lechel A, Feld FM, et al. Loss of ATM accelerates pancreatic cancer formation and epithelial-mesenchymal transition. Nat Commun. 2015;6:7677.","journal-title":"Nat Commun"},{"issue":"9","key":"1161_CR12","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1158\/1541-7786.MCR-10-0052","volume":"8","author":"P Ceppi","year":"2010","unstructured":"Ceppi P, Mudduluru G, Kumarswamy R, Rapa I, Scagliotti GV, Papotti M, et al. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol Cancer Res. 2010;8(9):1207\u201316.","journal-title":"Mol Cancer Res"},{"issue":"2","key":"1161_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.bcp.2015.01.002","volume":"94","author":"V Zuco","year":"2015","unstructured":"Zuco V, Cassinelli G, Cossa G, Gatti L, Favini E, Tortoreto M, et al. Targeting the invasive phenotype of cisplatin-resistant non-small cell lung cancer cells by a novel histone deacetylase inhibitor. Biochem Pharmacol. 2015;94(2):79\u201390.","journal-title":"Biochem Pharmacol"},{"issue":"40","key":"1161_CR14","doi-asserted-by":"publisher","first-page":"65157","DOI":"10.18632\/oncotarget.11214","volume":"7","author":"CH Dai","year":"2016","unstructured":"Dai CH, Chen P, Li J, Lan T, Chen YC, Qian H, et al. Co-inhibition of pol theta and HR genes efficiently synergize with cisplatin to suppress cisplatin-resistant lung cancer cells survival. Oncotarget. 2016;7(40):65157\u201370.","journal-title":"Oncotarget"},{"issue":"11","key":"1161_CR15","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/mc.22421","volume":"55","author":"Y Yao","year":"2016","unstructured":"Yao Y, Shi M, Liu S, Li Y, Guo K, Ci Y, et al. MARVELD1 modulates cell surface morphology and suppresses epithelial-mesenchymal transition in non-small cell lung cancer. Mol Carcinog. 2016;55(11):1714\u201327.","journal-title":"Mol Carcinog"},{"issue":"8","key":"1161_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1080\/15384047.2017.1345391","volume":"18","author":"F Zhang","year":"2017","unstructured":"Zhang F, Shen M, Yang L, Yang X, Tsai Y, Keng PC, et al. Simultaneous targeting of ATM and Mcl-1 increases cisplatin sensitivity of cisplatin-resistant non-small cell lung cancer. Cancer Biol Ther. 2017;18(8):606\u201315.","journal-title":"Cancer Biol Ther"},{"key":"1161_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.humpath.2016.07.007","volume":"58","author":"S Kim","year":"2016","unstructured":"Kim S, Koh J, Kim MY, Kwon D, Go H, Kim YA, et al. PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung. Hum Pathol. 2016;58:7\u201314.","journal-title":"Hum Pathol"},{"issue":"13","key":"1161_CR18","doi-asserted-by":"publisher","first-page":"15901","DOI":"10.18632\/oncotarget.7431","volume":"7","author":"CY Ock","year":"2016","unstructured":"Ock CY, Kim S, Keam B, Kim M, Kim TM, Kim JH, et al. PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinoma. Oncotarget. 2016;7(13):15901\u201314.","journal-title":"Oncotarget"},{"issue":"1","key":"1161_CR19","doi-asserted-by":"publisher","first-page":"7958","DOI":"10.1038\/s41598-017-08483-z","volume":"7","author":"L Yang","year":"2017","unstructured":"Yang L, Shen M, Xu LJ, Yang X, Tsai Y, Keng PC, et al. Enhancing NK cell-mediated cytotoxicity to cisplatin-resistant lung cancer cells via MEK\/Erk signaling inhibition. Sci Rep. 2017;7(1):7958.","journal-title":"Sci Rep"},{"issue":"4","key":"1161_CR20","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.3892\/ijo.2016.3632","volume":"49","author":"N Zhang","year":"2016","unstructured":"Zhang N, Zeng Y, Du W, Zhu J, Shen D, Liu Z, et al. The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6\/JAK\/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer. Int J Oncol. 2016;49(4):1360\u20138.","journal-title":"Int J Oncol"},{"issue":"6","key":"1161_CR21","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1007\/s10147-017-1161-7","volume":"22","author":"X Zhang","year":"2017","unstructured":"Zhang X, Zeng Y, Qu Q, Zhu J, Liu Z, Ning W, et al. PD-L1 induced by IFN-gamma from tumor-associated macrophages via the JAK\/STAT3 and PI3K\/AKT signaling pathways promoted progression of lung cancer. Int J Clin Oncol. 2017;22(6):1026\u201333.","journal-title":"Int J Clin Oncol"},{"key":"1161_CR22","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.ijbiomac.2017.03.123","volume":"102","author":"S Chen","year":"2017","unstructured":"Chen S, Zhang JQ, Chen JZ, Chen HX, Qiu FN, Yan ML, et al. The over expression of long non-coding RNA ANRIL promotes epithelial-mesenchymal transition by activating the ATM-E2F1 signaling pathway in pancreatic cancer: an in vivo and in vitro study. Int J Biol Macromol. 2017;102:718\u201328.","journal-title":"Int J Biol Macromol"},{"key":"1161_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.canlet.2016.12.040","volume":"390","author":"R Liu","year":"2017","unstructured":"Liu R, Tang J, Ding C, Liang W, Zhang L, Chen T, et al. The depletion of ATM inhibits colon cancer proliferation and migration via B56gamma2-mediated Chk1\/p53\/CD44 cascades. Cancer Lett. 2017;390:48\u201357.","journal-title":"Cancer Lett"},{"issue":"7","key":"1161_CR24","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.4049\/jimmunol.1501989","volume":"197","author":"K Ochodnicka-Mackovicova","year":"2016","unstructured":"Ochodnicka-Mackovicova K, Bahjat M, Maas C, van der Veen A, Bloedjes TA, de Bruin AM, et al. The DNA damage response regulates RAG1\/2 expression in pre-B cells through ATM-FOXO1 signaling. J Immunol. 2016;197(7):2918\u201329.","journal-title":"J Immunol"},{"issue":"5","key":"1161_CR25","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1269\/jrr.10039","volume":"51","author":"M Tomita","year":"2010","unstructured":"Tomita M. Involvement of DNA-PK and ATM in radiation- and heat-induced DNA damage recognition and apoptotic cell death. J Radiat Res. 2010;51(5):493\u2013501.","journal-title":"J Radiat Res"},{"issue":"25","key":"1161_CR26","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1038\/onc.2013.285","volume":"33","author":"HP Kim","year":"2014","unstructured":"Kim HP, Han SW, Song SH, Jeong EG, Lee MY, Hwang D, et al. Testican-1-mediated epithelial-mesenchymal transition signaling confers acquired resistance to lapatinib in HER2-positive gastric cancer. Oncogene. 2014;33(25):3334\u201341.","journal-title":"Oncogene"},{"issue":"21","key":"1161_CR27","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.4161\/cc.22225","volume":"11","author":"C Oliveras-Ferraros","year":"2012","unstructured":"Oliveras-Ferraros C, Corominas-Faja B, Cufi S, Vazquez-Martin A, Martin-Castillo B, Iglesias JM, et al. Epithelial-to-mesenchymal transition (EMT) confers primary resistance to trastuzumab (Herceptin). Cell Cycle. 2012;11(21):4020\u201332.","journal-title":"Cell Cycle"},{"issue":"9","key":"1161_CR28","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.molmed.2012.08.001","volume":"18","author":"GL Semenza","year":"2012","unstructured":"Semenza GL. Molecular mechanisms mediating metastasis of hypoxic breast cancer cells. Trends Mol Med. 2012;18(9):534\u201343.","journal-title":"Trends Mol Med"},{"issue":"6","key":"1161_CR29","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1172\/JCI38019","volume":"119","author":"H Acloque","year":"2009","unstructured":"Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest. 2009;119(6):1438\u201349.","journal-title":"J Clin Invest"},{"issue":"3","key":"1161_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm757","volume":"3","author":"MA Nieto","year":"2002","unstructured":"Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002;3(3):155\u201366.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"1161_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/jmcb\/mjs048","volume":"4","author":"M Sun","year":"2012","unstructured":"Sun M, Guo X, Qian X, Wang H, Yang C, Brinkman KL, et al. Activation of the ATM-snail pathway promotes breast cancer metastasis. J Mol Cell Biol. 2012;4(5):304\u201315.","journal-title":"J Mol Cell Biol"},{"key":"1161_CR32","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/srep01675","volume":"3","author":"YC Yu","year":"2013","unstructured":"Yu YC, Yang PM, Chuah QY, Huang YH, Peng CW, Lee YJ, et al. Radiation-induced senescence in securin-deficient cancer cells promotes cell invasion involving the IL-6\/STAT3 and PDGF-BB\/PDGFR pathways. Sci Rep. 2013;3:1675.","journal-title":"Sci Rep"},{"issue":"34","key":"1161_CR33","doi-asserted-by":"crossref","first-page":"55543","DOI":"10.18632\/oncotarget.10837","volume":"7","author":"L Yang","year":"2016","unstructured":"Yang L, Zhang F, Wang X, Tsai Y, Chuang KH, Keng PC, et al. A FASN-TGF-beta1-FASN regulatory loop contributes to high EMT\/metastatic potential of cisplatin-resistant non-small cell lung cancer. Oncotarget. 2016;7(34):55543\u201354.","journal-title":"Oncotarget"},{"issue":"8","key":"1161_CR34","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s12032-015-0655-2","volume":"32","author":"Y Wang","year":"2015","unstructured":"Wang Y, Wang H, Zhao Q, Xia Y, Hu X, Guo J. PD-L1 induces epithelial-to-mesenchymal transition via activating SREBP-1c in renal cell carcinoma. Med Oncol. 2015;32(8):212.","journal-title":"Med Oncol"},{"issue":"5","key":"1161_CR35","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1164\/rccm.201401-0188OC","volume":"190","author":"NA Braun","year":"2014","unstructured":"Braun NA, Celada LJ, Herazo-Maya JD, Abraham S, Shaginurova G, Sevin CM, et al. Blockade of the programmed death-1 pathway restores sarcoidosis CD4(+) T-cell proliferative capacity. Am J Respir Crit Care Med. 2014;190(5):560\u201371.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1161_CR36","doi-asserted-by":"publisher","first-page":"e1165377","DOI":"10.1080\/2162402X.2016.1165377","volume":"5","author":"BT Rekoske","year":"2016","unstructured":"Rekoske BT, Olson BM, McNeel DG. Antitumor vaccination of prostate cancer patients elicits PD-1\/PD-L1 regulated antigen-specific immune responses. Oncoimmunology. 2016;5(6):e1165377.","journal-title":"Oncoimmunology"},{"issue":"2","key":"1161_CR37","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1158\/1078-0432.CCR-16-1163","volume":"23","author":"AM Seifert","year":"2017","unstructured":"Seifert AM, Zeng S, Zhang JQ, Kim TS, Cohen NA, Beckman MJ, et al. PD-1\/PD-L1 blockade enhances T-cell activity and antitumor efficacy of Imatinib in gastrointestinal stromal tumors. Clin Cancer Res. 2017;23(2):454\u201365.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1161_CR38","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8(8):793\u2013800.","journal-title":"Nat Med"},{"issue":"10","key":"1161_CR39","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/annonc\/mdu242","volume":"25","author":"K Azuma","year":"2014","unstructured":"Azuma K, Ota K, Kawahara A, Hattori S, Iwama E, Harada T, et al. Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer. Ann Oncol. 2014;25(10):1935\u201340.","journal-title":"Ann Oncol"},{"issue":"17","key":"1161_CR40","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.1158\/1078-0432.CCR-15-0016","volume":"21","author":"K Ota","year":"2015","unstructured":"Ota K, Azuma K, Kawahara A, Hattori S, Iwama E, Tanizaki J, et al. Induction of PD-L1 expression by the EML4-ALK Oncoprotein and downstream signaling pathways in non-small cell lung Cancer. Clin Cancer Res. 2015;21(17):4014\u201321.","journal-title":"Clin Cancer Res"},{"issue":"46","key":"1161_CR41","doi-asserted-by":"crossref","first-page":"80506","DOI":"10.18632\/oncotarget.19193","volume":"8","author":"MJ Shen","year":"2017","unstructured":"Shen MJ, Xu LJ, Yang L, Tsai Y, Keng PC, Chen Y, et al. Radiation alters PD-L1\/NKG2D ligand levels in lung cancer cells and leads to immune escape from NK cell cytotoxicity via IL-6-MEK\/Erk signaling pathway. Oncotarget. 2017;8(46):80506\u201320.","journal-title":"Oncotarget"},{"issue":"15","key":"1161_CR42","doi-asserted-by":"publisher","first-page":"12650","DOI":"10.1074\/jbc.M210368200","volume":"278","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Cho YY, Petersen BL, Bode AM, Zhu F, Dong Z. Ataxia telangiectasia mutated proteins, MAPKs, and RSK2 are involved in the phosphorylation of STAT3. J Biol Chem. 2003;278(15):12650\u20139.","journal-title":"J Biol Chem"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13046-019-1161-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-019-1161-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T13:29:29Z","timestamp":1607174969000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-019-1161-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,8]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1161"],"URL":"https:\/\/doi.org\/10.1186\/s13046-019-1161-8","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,8]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study has been examined and certified by the Ethics Committee of the Second Affiliated Hospital of Soochow University, and informed consent was obtained from all participants included in the study, in agreement with institutional guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Second Affiliated Hospital of Soochow University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"149"}}